Background: Studies conducted in various animal models of joint pain showed an anti-nociceptive effect of intra-articular botulinum toxin type A (BoNT-A). Randomized controlled trials (RCTs) in humans suggest a potential effect but results are disparate.
Objectives: To assess the efficacy and safety of intra-articular BoNT-A for the treatment of joint pain.